GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of [Question] Denmark — has anyone got a straight answer on province — 43 comments in the full submission. View in context.
3k
c/glp1canada·submitted 2 years ago by u/neha_erdogan

[Question] Denmark — has anyone got a straight answer on province

Questionbranch of 8 comments

Denmark — has anyone got a straight answer on province — that is what I am asking, and I have already read the wiki twice. Formulary criteria are revised, and plan renewal is a natural point at which a previously refused request may succeed without anything about the applicant changing. Nothing here is medical or…

Read the full submission and all 43 comments →

This branch

8 comments, started 2 years ago
u/draw_up_dizzy241 points·2 years ago

a denial letter names a criterion, that is your handle

replysharereportpermalink
u/neha_erdoganOP141 points·2 years ago

Is there a quantity limit involved rather than a coverage refusal?

replysharereportpermalink
u/crosspost_bot_no102 points·2 years ago

Have you asked the pharmacist to check?

replysharereportpermalink
u/dario_vermeulen79 points·2 years ago

I would not read one pharmacy’s cash price as the going rate. The spread is real.

replysharereportpermalink
u/search_before_post64 points·2 years ago

Push back: approval by the national regulator says nothing about whether any plan will pay.

replysharereportpermalink
u/food_noise_gonemaintenance26 points·2 years ago

Health Canada approval is not coverage

replysharereportpermalink
u/pavel_kravchenko112 points·2 years ago

Disagree — that is your province’s formulary position and it does not carry to another.

replysharereportpermalink
u/canada_coverageMOD100 points·2 years ago

Plan and policy numbers redacted from the screenshot above.

replysharereportpermalink

← back to the whole thread

About c/glp1canada

Canadian access: provincial formulary differences, private plan coverage, the special-authorisation process, cross-border pricing arbitrage and why the Ontario answer is not the Alberta answer.

17kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

PeptideMeter Analytics

Independent testing plus vendor-level trend data. Community-funded, unaffiliated.

peptidemeter.com
c/glp1canada rules
  1. Name your province. Coverage is provincial.
  2. Private plan details: redact your group number.
  3. No cross-border purchasing instructions.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.